Latest Headlines
-
Labcorp Introduces AI-Powered Real-World Data Platform With AWS And Datavant To Accelerate Alzheimer's Research
4/14/2026
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a new AI-powered real-world data platform, designed to help researchers and biopharmaceutical companies analyze Alzheimer's disease-related data faster.
-
Biomark Diagnostics To Present Liquid Biopsy Platform At The Canadian Thoracic Society Research Forum
4/14/2026
BioMark Diagnostics Inc. (“BioMark” or the “Company”) a leading developer of liquid biopsy technologies for early cancer detection, is pleased to announce that the Company has been selected as one of the top four innovators to present its liquid biopsy platform at the annual Canadian Thoracic Society (CTS) Research Forum.
-
Waters Debuts Industry-First Extended-Range MALS Detector For UHPLC/UPLC, Powering Rapid Characterization Of Large Molecules
4/14/2026
Waters Corporation (NYSE: WAT) today announced the launch of the Waters omniDAWN™ Multi-Angle Light Scattering (MALS) Photometer, part of the Wyatt Technology Portfolio.
-
CU Denver Creates Lab-Grown Lung Model To Test Treatments More Effectively
4/13/2026
University of Colorado Denver (CU Denver) Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help advance the treatment of lung diseases which affect men and women differently.
-
Roche Receives CE Mark For New Elecsys NfL Blood Test To Detect Neuroinflammation In Multiple Sclerosis
4/13/2026
Roche announced today that its Elecsys Neurofilament Light Chain (NfL) test has received CE mark approval for the detection of neuroinflammation in patients diagnosed with relapsing remitting multiple sclerosis (RRMS).
-
bioMérieux Unveils Its BIOFIRE® SPOTFIRE® Molecular Testing Solution For The Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
4/9/2026
bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of BIOFIRE® SPOTFIRE® for pharmaceutical industries, where this innovative molecular testing system is designed to transform quality control.
-
Labware And Phizzle Partnership To Eliminate Manual Instrument Data Transfer In Pharmaceutical Cleanroom Labs
4/8/2026
LabWare, a global provider of laboratory informatics, and Phizzle, an innovator in laboratory data integration, today announced a partnership to simplify how regulated laboratories connect environmental monitoring instruments and move instrument data into LabWare LIMS.
-
Degasser For Volatile And Aggressive Chromatography Solvents
4/8/2026
Biotech Fluidics announce the DEGASi Integration HFIP - a high-performance online system designed to efficiently degas even the toughest solvents. This unique degasser is fully compatible with a wide range of volatile and aggressive liquids including Hexafluoroisopropanol (HFIP) and silanes but can also manage all other solvents used for GPC/SEC and HPLC.
-
Rune Labs Launches Parkinson's AI Companion Trained On The World's Largest Parkinson's Dataset
4/8/2026
Today, Rune Labs announced the launch of a personalized AI companion to provide always-on support for people with Parkinson’s disease. Powered by Anthropic's Claude and built on Rune Labs' proprietary longitudinal dataset, comprising millions of hours of wearable data and FDA-cleared symptom algorithms, StrivePD Guardian continuously analyzes patients' real-time data to deliver timely, context-aware guidance on symptoms, medications, daily experiences, and care goals.
-
Saladax Biomedical To Expand International Access To Drug Level Testing For Psychiatry And Oncology
4/7/2026
Saladax Biomedical, Inc., a leader in therapeutic drug monitoring (TDM) diagnostics for psychiatry and oncology, today announced a distribution agreement with Thermo Fisher Scientific to expand global access to high-quality TDM assays that support clinicians in optimizing patient outcomes.